Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer Eva Balslev Dorte L. Nielsen Malgorzata K. Tuxen Soeren Cold Ulla B. Tange 10.6084/m9.figshare.1623064.v1 https://tandf.figshare.com/articles/journal_contribution/Phase_II_study_of_neoadjuvant_pegylated_liposomal_doxorubicin_and_cyclophosphamide_177_trastuzumab_followed_by_docetaxel_in_locally_advanced_breast_cancer/1623064 Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer 2014-10-01 00:00:00 phase II study docetaxel trastuzumab cyclophosphamide breast cancer Phase II study neoadjuvant pegylated liposomal doxorubicin